SCHEMBL29517048

SCHEMBL29517048

CCc1cc(O)c(C(C)(C)C)cc1Sc1cc(C(C)(C)C)c(O)cc1CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.61
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
TP53 P04637 3/20 0.61
CYP3A4 P08684 3/20 0.61
HIF1A Q16665 3/20 0.61
TSHR P16473 2/20 0.61
MAPK1 P28482 2/20 0.61
TDP1 Q9NUW8 1/20 0.61
MAPT P10636 3/20 0.52
CYP1A2 P05177 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
HSPA5 P11021 2/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 2/20 0.44
LMNA P02545 3/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2484931 1.00 ALOX15 (0.61) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2483068 0.87 ALOX15 (0.56) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL27559201 0.85 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2477818 0.84 ALOX15 (0.53) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2484356 0.82 ALOX15 (0.54) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL31267398 0.82 ALOX15 (0.50) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2788258 0.82 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL29808669 0.82 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2485961 0.79 ALOX15 (0.70) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL8745976 0.79 ALOX15 (0.42) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112544-A1 ELECTROLYTIC CAPACITOR PANASONIC IP MAN CO LTD (JP) 2026-04-23 US disclosed
WO-2022065434-A1 ELECTROLYTIC CAPACITOR パナソニックIPマネジメント株式会社 2022-03-31 WO disclosed
WO-2022025189-A1 ELECTROLYTIC CAPACITOR パナソニックIPマネジメント株式会社 2022-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260112544-A1 ELECTROLYTIC CAPACITOR ASIC1, SLC9A2, SLC25A13 ALOX15 1941/4885ALDH1A1 508/4885SMN1; SMN2 2688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.